Evidence map›Paper›PMID 36616174›Full record

ArticlePlants (Basel, Switzerland)2022

Pyramiding of Four Broad Spectrum Bacterial Blight Resistance Genes in Cross Breeds of Basmati Rice.

Irfan Ullah, Hamid Ali, Tariq Mahmood, Mudassar Nawaz Khan, Muhammad Haris, Hussain Shah, Adil Mihoub, Aftab Jamal, Muhammad Farhan Saeed, Roberto Mancinelli and 1 more

Open access · goldAbstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Resistance gene againstFrontiers in plant science · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Marker-assisted enhancement of bacterial blight (Frontiers in plant science · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 3 countries.

Irfan UllahDepartment of Biotechnology and Genetic Engineering, Hazara University Mansehra, Mansehra 21300, Pakistan.ORCID 0000-0002-8235-8238
Hamid AliDepartment of Biotechnology and Genetic Engineering, Hazara University Mansehra, Mansehra 21300, Pakistan.
Tariq MahmoodDepartment of Agriculture, Hazara University Mansehra, Mansehra 21300, Pakistan.
Mudassar Nawaz KhanDepartment of Biotechnology and Genetic Engineering, Hazara University Mansehra, Mansehra 21300, Pakistan.ORCID 0000-0001-7127-2239
Muhammad HarisDepartment of Biotechnology and Genetic Engineering, Hazara University Mansehra, Mansehra 21300, Pakistan.
Hussain ShahPlant Sciences Division, Pakistan Agricultural Research Council Islamabad, Islamabad 45500, Pakistan.
Adil MihoubCenter for Scientific and Technical Research on Arid Regions, Biophysical Environment Station, Toug-gourt 30240, Algeria.ORCID 0000-0002-7869-700X
Aftab JamalDepartment of Soil and Environmental Sciences, Faculty of Crop Production Sciences, The University of Agriculture, Peshawar 25130, Pakistan.ORCID 0000-0001-8518-3130
Muhammad Farhan SaeedDepartment of Environmental Sciences, Vehari-Campus, COMSATS University Islamabad, Vehari 61100, Pakistan.ORCID 0000-0002-7144-6443
Roberto MancinelliDepartment of Agricultural and Forestry Sciences (DAFNE), University of Tuscia, 01100 Viterbo, Italy.ORCID 0000-0002-8396-6307
Emanuele RadicettiDepartment of Chemical, Pharmaceutical and Agricultural Sciences (DOCPAS), University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0001-8654-3177
Hazara University · PKCOMSATS University Islamabad · PKCRSTRA · DZPakistan Agricultural Research Council · PKThe University of Agriculture, Peshawar · PKUniversità degli Studi della Tuscia · ITUniversity of Ferrara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pyramiding of major resistance (R) genes through marker-assisted selection (MAS) is a useful way to attain durable and broad-spectrum resistance against Xanthomonas oryzae pv. oryzae pathogen, the causal agent of bacterial blight (BB) disease in rice (Oryza sativa L.). The present study was designed to pyramid four broad spectrum BB-R genes (Xa4, xa5, xa13 and Xa21) in the background of Basmati-385, an indica rice cultivar with much sought-after qualitative and quantitative grain traits. The cultivar, however, is susceptible to BB and was therefore, crossed with IRBB59 which possesses R genes xa5, xa13 and Xa21, to attain broad and durable resistance. A total of 19 F1 plants were obtained, some of which were backcrossed with Basmati-385 and large number of BC1F1 plants were obtained. In BC1F2 generation, 31 phenotypically superior genotypes having morphological features of Basmati-385, were selected and advanced up to BC1F6 population. Sequence-tagged site (STS)-based MAS was carried out and phenotypic selection was made in each successive generation. In BC1F6 population, potentially homozygous recombinant inbred lines (RILs) from each line were selected and evaluated on the bases of STS evaluation and resistance to local Xanthomonas oryzae pv. oryzae (Xoo) isolates. Line 23 was found pyramided with all four BB-R genes i.e., Xa4, xa5, xa13 and Xa21. Five genotypes including line 8, line 16, line 21, line 27 and line 28 were identified as pyramided with three R genes, Xa4, xa5 and xa13. Pathological study showed that rice lines pyramided with quadruplet or triplet R genes showed the highest level of resistance compared to doublet or singlet R genes. Thus, line 23 with quadruplet, and lines 8, 16, 21, 27, and 28 with triplet R genes, are recommended for replicated yield and resistance trials before release as new rice varieties. Further, traditional breeding coupled with MAS, is a solid way to attain highly effective BB-resistant rice lines with no yield cost.

Indexed as

bacterial blightBasmati-385Oryza sativapyramidingrecombinant inbred linesresponse

Identifiers

PMID36616174
PMCPMC9824772
OpenAlexW4312100570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.